CFDE Data Portal | Search MTND1P23

	Label	Description
	MTND1P23 Gene (Entity type)	ENSG00000225972 - MT-ND1 pseudogene 23
	MTND1P23 associations Collection (Entity type)	Associations for MTND1P23_associations
	MTND1P23 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE213588 trametinib NF1 9 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE222758 clofazimine U2OS 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE156761 dopamine neuron 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

MTND1P23

ENSG00000225972 - MT-ND1 pseudogene 23

MTND1P23 associations

Associations for MTND1P23_associations

MTND1P23 associations.tsv

A file from IDG as part of the Harmonizome project

GSE213588 trametinib NF1 9 v 11 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human dn

A Gene Set from LINCS

GSE222758 clofazimine U2OS 0 v 2 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 0 v 1 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 8 human dn

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 5 human up

A Gene Set from LINCS

GSE156761 dopamine neuron 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.